drugset / Trial / NCT01858480

Study To Evaluate D-Ribose For The Treatment of Congestive Heart Failure

NCT01858480

Phase 2 Withdrawn RiboCor, Inc.
RandomizedParallel-groupTriple-blindTreatment

Summary

To evaluate the safety and to determine the efficacy of D-ribose for the treatment of congestive heart failure (CHF) in subjects who have been stabilized following hospitalization with acute decompensation.

Timeline

Start
2013-07
Primary completion
2013-11
Completion
2013-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator RIBOSE (PYRANOSE) Small molecule Intravenous